Envestnet Portfolio Solutions Inc. Purchases 3,873 Shares of The Clorox Company (NYSE:CLX)

Envestnet Portfolio Solutions Inc. lifted its position in shares of The Clorox Company (NYSE:CLX) by 17.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,755 shares of the company’s stock after purchasing an additional 3,873 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Clorox were worth $4,183,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in CLX. Brooklyn Investment Group grew its holdings in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the third quarter worth $27,000. Continuum Advisory LLC grew its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Asset Planning Inc acquired a new stake in Clorox in the fourth quarter valued at $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new position in shares of Clorox in the fourth quarter worth approximately $36,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $144.70 on Wednesday. The stock has a market cap of $17.83 billion, a price-to-earnings ratio of 39.54, a PEG ratio of 2.62 and a beta of 0.45. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The firm’s 50-day simple moving average is $153.71 and its 200 day simple moving average is $160.08.

Clorox (NYSE:CLX) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm earned $2.16 EPS. As a group, research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.37%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is 133.33%.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent analyst reports. Wells Fargo & Company boosted their target price on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Barclays boosted their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. Finally, Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.